V003415
Hydrochloric acid
USP, 36.5-38.0%
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
HCl
CAS Number:
Molecular Weight:
36.46
Beilstein/REAXYS Number:
1098214
MDL number:
agency
USP
vapor density
1.3 (vs air)
vapor pressure
3.23 psi ( 21.1 °C), 7.93 psi ( 37.7 °C)
concentration
36.5-38.0%
bp
>100 °C (lit.)
density
1.18 g/mL at 20 °C
SMILES string
Cl
InChI
1S/ClH/h1H
InChI key
VEXZGXHMUGYJMC-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under Hydrochloric acid
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 3 Inhalation - Eye Dam. 1 - Press. Gas Compr. Gas - Skin Corr. 1A
Storage Class
2A - Gases
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Douglas M McMillan et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(7), 1804-1812 (2015-01-30)
CYP2D metabolically activates codeine to morphine, which is required for codeine analgesia. Permeability across the blood-brain barrier, and active efflux, suggests that initial morphine in the brain after codeine is due to brain CYP2D metabolism. Human CYP2D is higher in
Marta Kolodziejczak et al.
ACS chemical neuroscience, 6(7), 1219-1230 (2015-04-11)
Maturation of functional neuronal circuits during central nervous system development relies on sophisticated mechanisms. First, axonal and dendritic growth should reach appropriate targets for correct synapse elaboration. Second, pruning and neuronal death are required to eliminate redundant or inappropriate neuronal
Jay G Hosking et al.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 40(4), 1005-1015 (2014-10-21)
Successful decision making often requires weighing a given option's costs against its associated benefits, an ability that appears perturbed in virtually every severe mental illness. Animal models of such cost/benefit decision making overwhelmingly implicate mesolimbic dopamine in our willingness to